Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Vifor Pharma reports new regulatory submission for PA-21 in Switzerland

March 13, 2013

Health Canada approves mirabegron

March 11, 2013

DSP and Nippon Shinyaku sign Japanese agreement for SMP-986

March 8, 2013

OPKO Health completes acquisition

March 6, 2013

FDA agrees with La Jolla Pharmaceutical's proposed IND for LJPC-501

March 5, 2013

Ventana and Biocare Medical sign license agreement for diagnosis of prostate lesions

March 1, 2013

Mirabegron launched in the U.K. for treatment of overactive bladder

Feb. 26, 2013

Purdue Pharma prepares new TRPV1 antagonists

Feb. 26, 2013

Relypsa enrolls first patient in pivotal phase III patiromer trial

Feb. 22, 2013

Encouraging immunogenicity results reported from phase III program for NX-1207

Feb. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...